

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 4-hydroxyproline metabolic process (GO:0019471) | 6.35131651 |
| 2 | peptidyl-proline hydroxylation (GO:0019511) | 5.41978302 |
| 3 | protein hydroxylation (GO:0018126) | 5.18872534 |
| 4 | intestinal cholesterol absorption (GO:0030299) | 5.13441013 |
| 5 | toxin transport (GO:1901998) | 4.73788666 |
| 6 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.64834625 |
| 7 | artery smooth muscle contraction (GO:0014824) | 4.61450744 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.38439954 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.38439954 |
| 10 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 4.31637700 |
| 11 | labyrinthine layer development (GO:0060711) | 4.12210646 |
| 12 | xenobiotic catabolic process (GO:0042178) | 4.08513138 |
| 13 | tonic smooth muscle contraction (GO:0014820) | 4.01638936 |
| 14 | heart trabecula formation (GO:0060347) | 3.91655439 |
| 15 | succinate metabolic process (GO:0006105) | 3.82386399 |
| 16 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.67714515 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 3.67479294 |
| 18 | nephron tubule formation (GO:0072079) | 3.67298738 |
| 19 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.66792718 |
| 20 | positive regulation of digestive system process (GO:0060456) | 3.53856206 |
| 21 | positive regulation of hormone metabolic process (GO:0032352) | 3.53659988 |
| 22 | daunorubicin metabolic process (GO:0044597) | 3.53184438 |
| 23 | polyketide metabolic process (GO:0030638) | 3.53184438 |
| 24 | doxorubicin metabolic process (GO:0044598) | 3.53184438 |
| 25 | drug transmembrane transport (GO:0006855) | 3.50356984 |
| 26 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.50114874 |
| 27 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.50114874 |
| 28 | nephron epithelium morphogenesis (GO:0072088) | 3.48417625 |
| 29 | nephron tubule morphogenesis (GO:0072078) | 3.48417625 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 3.42816687 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.42816687 |
| 32 | reverse cholesterol transport (GO:0043691) | 3.42240482 |
| 33 | cholesterol efflux (GO:0033344) | 3.40325187 |
| 34 | response to nitric oxide (GO:0071731) | 3.35145237 |
| 35 | macromolecular complex remodeling (GO:0034367) | 3.32647743 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 3.32647743 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 3.32647743 |
| 38 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.25329376 |
| 39 | GDP-mannose metabolic process (GO:0019673) | 3.24685895 |
| 40 | pharyngeal system development (GO:0060037) | 3.16657426 |
| 41 | ventricular septum morphogenesis (GO:0060412) | 3.15787093 |
| 42 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.13250479 |
| 43 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.11480871 |
| 44 | low-density lipoprotein particle remodeling (GO:0034374) | 3.10951780 |
| 45 | plasma lipoprotein particle clearance (GO:0034381) | 3.09459785 |
| 46 | phasic smooth muscle contraction (GO:0014821) | 3.07369072 |
| 47 | carnitine transmembrane transport (GO:1902603) | 3.04737897 |
| 48 | digestion (GO:0007586) | 3.03580370 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 3.01941147 |
| 50 | protein carboxylation (GO:0018214) | 3.00803509 |
| 51 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.00803509 |
| 52 | amino-acid betaine transport (GO:0015838) | 3.00601374 |
| 53 | carnitine transport (GO:0015879) | 3.00601374 |
| 54 | ribosomal small subunit assembly (GO:0000028) | 2.99773926 |
| 55 | tricarboxylic acid cycle (GO:0006099) | 2.97326965 |
| 56 | lung epithelium development (GO:0060428) | 2.97115478 |
| 57 | organic cation transport (GO:0015695) | 2.90427814 |
| 58 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.88358634 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 2.87577356 |
| 60 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.86159787 |
| 61 | vascular smooth muscle contraction (GO:0014829) | 2.86126762 |
| 62 | cellular zinc ion homeostasis (GO:0006882) | 2.84951407 |
| 63 | cholesterol transport (GO:0030301) | 2.78114935 |
| 64 | sterol transport (GO:0015918) | 2.78114935 |
| 65 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.76860661 |
| 66 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.76805555 |
| 67 | low-density lipoprotein particle clearance (GO:0034383) | 2.75088924 |
| 68 | regulation of bile acid biosynthetic process (GO:0070857) | 2.74957615 |
| 69 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.73939787 |
| 70 | positive regulation of mitochondrial fission (GO:0090141) | 2.71242185 |
| 71 | macroautophagy (GO:0016236) | 2.70297569 |
| 72 | plasma lipoprotein particle organization (GO:0071827) | 2.70083834 |
| 73 | proteasome assembly (GO:0043248) | 2.68698238 |
| 74 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.68396591 |
| 75 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.68396591 |
| 76 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.68396591 |
| 77 | regulation of apoptotic cell clearance (GO:2000425) | 2.67964747 |
| 78 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.67722416 |
| 79 | coenzyme catabolic process (GO:0009109) | 2.67665948 |
| 80 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.67167575 |
| 81 | negative regulation of sterol transport (GO:0032372) | 2.67028353 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 2.67028353 |
| 83 | mannosylation (GO:0097502) | 2.66685819 |
| 84 | quaternary ammonium group transport (GO:0015697) | 2.66595288 |
| 85 | negative regulation of epidermis development (GO:0045683) | 2.64849801 |
| 86 | intestinal absorption (GO:0050892) | 2.63124236 |
| 87 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.63015235 |
| 88 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.62493065 |
| 89 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.60989579 |
| 90 | cardiac septum morphogenesis (GO:0060411) | 2.60945804 |
| 91 | rRNA transcription (GO:0009303) | 2.59974801 |
| 92 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.59641658 |
| 93 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.55692159 |
| 94 | regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418) | 2.55075809 |
| 95 | drug transport (GO:0015893) | 2.54777539 |
| 96 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.54729698 |
| 97 | establishment of planar polarity (GO:0001736) | 2.53904493 |
| 98 | establishment of tissue polarity (GO:0007164) | 2.53904493 |
| 99 | peristalsis (GO:0030432) | 2.53006265 |
| 100 | energy homeostasis (GO:0097009) | 2.52668537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.18413148 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 5.04059133 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.84792066 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.95854846 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.92942333 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.23667093 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.19346402 |
| 8 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.14806918 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.94729578 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.67465177 |
| 11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.61328789 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50821743 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.50434949 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.30904609 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.24450784 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.16445582 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.16389498 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02528976 |
| 19 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.91189869 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.90077738 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.84492406 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.82185866 |
| 23 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.81546657 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.73871231 |
| 25 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.72955399 |
| 26 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.66912549 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.66820039 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.65963638 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.64221072 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.62246746 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.60762770 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56356668 |
| 33 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.55886466 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.55671072 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52283420 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50565050 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47517068 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.43779710 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42717880 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40098000 |
| 41 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.39487706 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.38080838 |
| 43 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.37735452 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36960957 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.36106699 |
| 46 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34657218 |
| 47 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.33774699 |
| 48 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.32069491 |
| 49 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.31479897 |
| 50 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.27944616 |
| 51 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.26682528 |
| 52 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24254193 |
| 53 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.23245072 |
| 54 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22518610 |
| 55 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.21578417 |
| 56 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17868919 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17545244 |
| 58 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16457464 |
| 59 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.16129777 |
| 60 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15237983 |
| 61 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.14691445 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13948111 |
| 63 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09609972 |
| 64 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08958776 |
| 65 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.07543981 |
| 66 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07329200 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06970887 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05615252 |
| 69 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.04681550 |
| 70 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.00846428 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00702535 |
| 72 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.99994704 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96715992 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95221537 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95195500 |
| 76 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.93072556 |
| 77 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92781504 |
| 78 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92573502 |
| 79 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91416683 |
| 80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90649382 |
| 81 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.88633594 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.88521039 |
| 83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88189264 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.87601409 |
| 85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.87601409 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.86914282 |
| 87 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85947498 |
| 88 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85242318 |
| 89 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85171895 |
| 90 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.84820109 |
| 91 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.84160657 |
| 92 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.81991307 |
| 93 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81736637 |
| 94 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81638564 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81542896 |
| 96 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.81493427 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 0.80320928 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80120446 |
| 99 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.79962226 |
| 100 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.79237830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000566_synostosis | 4.46691632 |
| 2 | MP0005083_abnormal_biliary_tract | 4.12887896 |
| 3 | MP0005365_abnormal_bile_salt | 3.70914595 |
| 4 | MP0003195_calcinosis | 3.56631477 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.46883112 |
| 6 | MP0005084_abnormal_gallbladder_morpholo | 3.26896445 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.19278506 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.01022253 |
| 9 | MP0009840_abnormal_foam_cell | 2.89403813 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.81114494 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.77939495 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.66479413 |
| 13 | MP0003283_abnormal_digestive_organ | 2.50800583 |
| 14 | MP0000383_abnormal_hair_follicle | 2.34602563 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.29812607 |
| 16 | MP0005408_hypopigmentation | 2.29491864 |
| 17 | MP0010678_abnormal_skin_adnexa | 2.19133729 |
| 18 | MP0003252_abnormal_bile_duct | 2.18954269 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.12141293 |
| 20 | MP0003122_maternal_imprinting | 2.02113832 |
| 21 | MP0003868_abnormal_feces_composition | 1.97213799 |
| 22 | MP0002938_white_spotting | 1.96688208 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.85256840 |
| 24 | MP0000613_abnormal_salivary_gland | 1.82801725 |
| 25 | MP0003942_abnormal_urinary_system | 1.77336689 |
| 26 | MP0005379_endocrine/exocrine_gland_phen | 1.75768753 |
| 27 | MP0002132_abnormal_respiratory_system | 1.73698506 |
| 28 | MP0005332_abnormal_amino_acid | 1.72615703 |
| 29 | MP0002254_reproductive_system_inflammat | 1.69534828 |
| 30 | MP0000462_abnormal_digestive_system | 1.68143339 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.67561527 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.58453812 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.54019946 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.52974493 |
| 35 | MP0002160_abnormal_reproductive_system | 1.44518968 |
| 36 | MP0008995_early_reproductive_senescence | 1.40112281 |
| 37 | MP0000538_abnormal_urinary_bladder | 1.35280097 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.31047093 |
| 39 | MP0005360_urolithiasis | 1.24192962 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.23777570 |
| 41 | MP0005220_abnormal_exocrine_pancreas | 1.22960850 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.22432964 |
| 43 | MP0001756_abnormal_urination | 1.21209566 |
| 44 | MP0003121_genomic_imprinting | 1.18070070 |
| 45 | MP0003941_abnormal_skin_development | 1.16975467 |
| 46 | MP0002234_abnormal_pharynx_morphology | 1.15602026 |
| 47 | MP0002282_abnormal_trachea_morphology | 1.10454944 |
| 48 | MP0000534_abnormal_ureter_morphology | 1.08419142 |
| 49 | MP0000639_abnormal_adrenal_gland | 1.08068759 |
| 50 | MP0002928_abnormal_bile_duct | 1.06012114 |
| 51 | MP0003123_paternal_imprinting | 1.05014658 |
| 52 | MP0009053_abnormal_anal_canal | 1.00133648 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 0.96649842 |
| 54 | MP0008961_abnormal_basal_metabolism | 0.94166288 |
| 55 | MP0000013_abnormal_adipose_tissue | 0.93824502 |
| 56 | MP0002909_abnormal_adrenal_gland | 0.91676547 |
| 57 | MP0003950_abnormal_plasma_membrane | 0.91562860 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 0.89541864 |
| 59 | MP0002089_abnormal_postnatal_growth/wei | 0.87961304 |
| 60 | MP0003755_abnormal_palate_morphology | 0.87234207 |
| 61 | MP0002118_abnormal_lipid_homeostasis | 0.85160306 |
| 62 | MP0004233_abnormal_muscle_weight | 0.84527097 |
| 63 | MP0009046_muscle_twitch | 0.84347657 |
| 64 | MP0004272_abnormal_basement_membrane | 0.83301108 |
| 65 | MP0004484_altered_response_of | 0.81461503 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 0.79372599 |
| 67 | MP0000681_abnormal_thyroid_gland | 0.78915945 |
| 68 | MP0008007_abnormal_cellular_replicative | 0.77413705 |
| 69 | MP0003718_maternal_effect | 0.77352074 |
| 70 | MP0001661_extended_life_span | 0.75065247 |
| 71 | MP0000598_abnormal_liver_morphology | 0.74018727 |
| 72 | MP0001873_stomach_inflammation | 0.73858005 |
| 73 | MP0005187_abnormal_penis_morphology | 0.73152204 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.72319420 |
| 75 | MP0002751_abnormal_autonomic_nervous | 0.72279910 |
| 76 | MP0000371_diluted_coat_color | 0.71553875 |
| 77 | MP0005646_abnormal_pituitary_gland | 0.70032852 |
| 78 | MP0005389_reproductive_system_phenotype | 0.69407989 |
| 79 | MP0004134_abnormal_chest_morphology | 0.69115993 |
| 80 | MP0005330_cardiomyopathy | 0.68853543 |
| 81 | MP0003943_abnormal_hepatobiliary_system | 0.66565826 |
| 82 | MP0003115_abnormal_respiratory_system | 0.66284135 |
| 83 | MP0003786_premature_aging | 0.66078669 |
| 84 | MP0003953_abnormal_hormone_level | 0.66037124 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.65880556 |
| 86 | MP0003959_abnormal_lean_body | 0.65785955 |
| 87 | MP0000049_abnormal_middle_ear | 0.64165613 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 0.63836333 |
| 89 | MP0006035_abnormal_mitochondrial_morpho | 0.63219252 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.62913653 |
| 91 | MP0005448_abnormal_energy_balance | 0.62801626 |
| 92 | MP0001145_abnormal_male_reproductive | 0.62479495 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.62090414 |
| 94 | MP0003315_abnormal_perineum_morphology | 0.61995567 |
| 95 | MP0005670_abnormal_white_adipose | 0.61183793 |
| 96 | MP0000467_abnormal_esophagus_morphology | 0.60920327 |
| 97 | MP0000609_abnormal_liver_physiology | 0.60438950 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 0.59438632 |
| 99 | MP0000920_abnormal_myelination | 0.56896975 |
| 100 | MP0002163_abnormal_gland_morphology | 0.56631700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperventilation (HP:0002883) | 5.82204117 |
| 2 | Methylmalonic aciduria (HP:0012120) | 4.55904569 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.42962322 |
| 4 | Humeroradial synostosis (HP:0003041) | 3.74601127 |
| 5 | Synostosis involving the elbow (HP:0003938) | 3.74601127 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 3.65107103 |
| 7 | Cerebellar dysplasia (HP:0007033) | 3.59175287 |
| 8 | Vascular calcification (HP:0004934) | 3.38161023 |
| 9 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.33485869 |
| 10 | Short 1st metacarpal (HP:0010034) | 3.24716399 |
| 11 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.24716399 |
| 12 | Deep venous thrombosis (HP:0002625) | 3.13950143 |
| 13 | Onycholysis (HP:0001806) | 2.98601198 |
| 14 | Abnormality of the 1st metacarpal (HP:0010009) | 2.98490018 |
| 15 | Cardiovascular calcification (HP:0011915) | 2.89558785 |
| 16 | Steatorrhea (HP:0002570) | 2.86142791 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 2.85544241 |
| 18 | Loss of speech (HP:0002371) | 2.82267273 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 2.81088219 |
| 20 | Abnormality of the pons (HP:0007361) | 2.68996857 |
| 21 | Vertebral hypoplasia (HP:0008417) | 2.67069031 |
| 22 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.67069031 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 2.64954770 |
| 24 | Dicarboxylic aciduria (HP:0003215) | 2.63924721 |
| 25 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63924721 |
| 26 | Glycosuria (HP:0003076) | 2.63687225 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 2.63687225 |
| 28 | Fat malabsorption (HP:0002630) | 2.62590332 |
| 29 | Amblyopia (HP:0000646) | 2.60567953 |
| 30 | Microretrognathia (HP:0000308) | 2.59804066 |
| 31 | Hypoplasia of the pons (HP:0012110) | 2.59645180 |
| 32 | Confusion (HP:0001289) | 2.53333751 |
| 33 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.51933051 |
| 34 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.51933051 |
| 35 | Abnormal protein glycosylation (HP:0012346) | 2.51933051 |
| 36 | Abnormal glycosylation (HP:0012345) | 2.51933051 |
| 37 | Cortical visual impairment (HP:0100704) | 2.51133250 |
| 38 | Enlarged kidneys (HP:0000105) | 2.43944637 |
| 39 | Right ventricular cardiomyopathy (HP:0011663) | 2.43790502 |
| 40 | Abnormality of glycolysis (HP:0004366) | 2.43375268 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.41592058 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39702148 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.39702148 |
| 44 | Facial shape deformation (HP:0011334) | 2.39553565 |
| 45 | Potter facies (HP:0002009) | 2.39553565 |
| 46 | Xanthomatosis (HP:0000991) | 2.36739849 |
| 47 | Hyperammonemia (HP:0001987) | 2.35242108 |
| 48 | Hypomagnesemia (HP:0002917) | 2.29979412 |
| 49 | Hyperglycinemia (HP:0002154) | 2.26860445 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26408055 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26408055 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26408055 |
| 53 | Respiratory failure (HP:0002878) | 2.25384494 |
| 54 | Increased serum pyruvate (HP:0003542) | 2.24097997 |
| 55 | Epidermoid cyst (HP:0200040) | 2.15599006 |
| 56 | Polycythemia (HP:0001901) | 2.15456563 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.12056762 |
| 58 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.11404729 |
| 59 | Hypoplasia of the uterus (HP:0000013) | 2.09806345 |
| 60 | Joint hemorrhage (HP:0005261) | 2.06106162 |
| 61 | Short phalanx of the thumb (HP:0009660) | 2.02283450 |
| 62 | Acute encephalopathy (HP:0006846) | 2.00798976 |
| 63 | Absent eyebrow (HP:0002223) | 1.99343694 |
| 64 | Abnormal tarsal ossification (HP:0008369) | 1.98008735 |
| 65 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.97996646 |
| 66 | Hypoglycemic coma (HP:0001325) | 1.97368303 |
| 67 | Unilateral renal agenesis (HP:0000122) | 1.93343564 |
| 68 | Abnormality of renal resorption (HP:0011038) | 1.92670385 |
| 69 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.92557297 |
| 70 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.88868491 |
| 71 | Abnormal sex determination (HP:0012244) | 1.88027279 |
| 72 | Sex reversal (HP:0012245) | 1.88027279 |
| 73 | Hepatic necrosis (HP:0002605) | 1.88016151 |
| 74 | Type II lissencephaly (HP:0007260) | 1.87154236 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86955578 |
| 76 | Gonadal dysgenesis (HP:0000133) | 1.85676385 |
| 77 | Pancreatic cysts (HP:0001737) | 1.84159299 |
| 78 | Abnormality of renal excretion (HP:0011036) | 1.83737125 |
| 79 | Abnormality of alanine metabolism (HP:0010916) | 1.82988730 |
| 80 | Hyperalaninemia (HP:0003348) | 1.82988730 |
| 81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82988730 |
| 82 | Abnormality of the renal medulla (HP:0100957) | 1.81639240 |
| 83 | Respiratory distress (HP:0002098) | 1.81147071 |
| 84 | Prolonged neonatal jaundice (HP:0006579) | 1.80315690 |
| 85 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.80059807 |
| 86 | Bicornuate uterus (HP:0000813) | 1.79229934 |
| 87 | Abnormality of the vitreous humor (HP:0004327) | 1.79085811 |
| 88 | Occipital encephalocele (HP:0002085) | 1.77671876 |
| 89 | Facial cleft (HP:0002006) | 1.77603563 |
| 90 | Increased CSF protein (HP:0002922) | 1.77176299 |
| 91 | Hypophosphatemia (HP:0002148) | 1.76807722 |
| 92 | Abnormality of magnesium homeostasis (HP:0004921) | 1.74985140 |
| 93 | Short hallux (HP:0010109) | 1.74618335 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 1.73623101 |
| 95 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.73120139 |
| 96 | Cystic liver disease (HP:0006706) | 1.73051373 |
| 97 | Hypolipoproteinemia (HP:0010981) | 1.73044290 |
| 98 | Broad distal phalanx of finger (HP:0009836) | 1.71155485 |
| 99 | Cardiomegaly (HP:0001640) | 1.71101189 |
| 100 | Unsteady gait (HP:0002317) | 1.68434462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 6.12107494 |
| 2 | SCYL2 | 3.48242819 |
| 3 | TAOK3 | 3.00011923 |
| 4 | CDK8 | 2.96647061 |
| 5 | PNCK | 2.83124410 |
| 6 | FGFR4 | 2.64358446 |
| 7 | PDK2 | 2.48575496 |
| 8 | TAF1 | 2.33093898 |
| 9 | EPHA2 | 2.25558810 |
| 10 | STK39 | 2.25552544 |
| 11 | CASK | 2.08730152 |
| 12 | TGFBR2 | 2.07506045 |
| 13 | FGFR2 | 2.04689114 |
| 14 | TSSK6 | 1.99803048 |
| 15 | GRK7 | 1.94515718 |
| 16 | VRK2 | 1.94263454 |
| 17 | GRK1 | 1.85468794 |
| 18 | MAP3K12 | 1.83106185 |
| 19 | STK38L | 1.73846165 |
| 20 | MAP3K4 | 1.68774622 |
| 21 | ZAK | 1.55588870 |
| 22 | MUSK | 1.52724822 |
| 23 | CSNK1G3 | 1.50379110 |
| 24 | BCKDK | 1.47069334 |
| 25 | MAPK7 | 1.42122063 |
| 26 | CSNK1A1L | 1.38486844 |
| 27 | MAP2K3 | 1.37439313 |
| 28 | OXSR1 | 1.36705561 |
| 29 | NME2 | 1.33560208 |
| 30 | FGFR3 | 1.31659400 |
| 31 | CSNK1G1 | 1.26867133 |
| 32 | RPS6KB2 | 1.26498610 |
| 33 | MAP3K3 | 1.24489751 |
| 34 | MAP2K6 | 1.21389955 |
| 35 | SMG1 | 1.19130504 |
| 36 | FRK | 1.16552180 |
| 37 | MST4 | 1.11707544 |
| 38 | WNK4 | 1.06934197 |
| 39 | PIK3CA | 1.05382908 |
| 40 | VRK1 | 1.01546942 |
| 41 | FGFR1 | 0.99219679 |
| 42 | CSNK1G2 | 0.98536286 |
| 43 | LIMK1 | 0.97233491 |
| 44 | TLK1 | 0.96844825 |
| 45 | TRIB3 | 0.94228182 |
| 46 | MAP3K6 | 0.94082272 |
| 47 | IRAK3 | 0.90590645 |
| 48 | STK16 | 0.84389917 |
| 49 | RET | 0.83221775 |
| 50 | PLK4 | 0.74213981 |
| 51 | CHUK | 0.73750524 |
| 52 | DAPK3 | 0.71885249 |
| 53 | MYLK | 0.68593556 |
| 54 | WEE1 | 0.65252454 |
| 55 | PDPK1 | 0.64768611 |
| 56 | AKT2 | 0.64663127 |
| 57 | MAP2K4 | 0.64502868 |
| 58 | RPS6KB1 | 0.63022094 |
| 59 | BRSK1 | 0.62912297 |
| 60 | PTK2 | 0.62344906 |
| 61 | STK4 | 0.62304968 |
| 62 | MAPKAPK3 | 0.62167045 |
| 63 | SIK1 | 0.60615125 |
| 64 | MAPK15 | 0.60240422 |
| 65 | NEK6 | 0.59639608 |
| 66 | ADRBK1 | 0.58704304 |
| 67 | DYRK1B | 0.55747324 |
| 68 | DAPK1 | 0.55439341 |
| 69 | ERBB2 | 0.55115842 |
| 70 | PRKCE | 0.55111898 |
| 71 | CAMK2D | 0.53663967 |
| 72 | ICK | 0.52692271 |
| 73 | PLK2 | 0.51641966 |
| 74 | ILK | 0.50763818 |
| 75 | GRK5 | 0.49764347 |
| 76 | PRKCI | 0.49210410 |
| 77 | AKT3 | 0.48763432 |
| 78 | CAMK1G | 0.48593140 |
| 79 | CSNK1D | 0.47915075 |
| 80 | LRRK2 | 0.45601845 |
| 81 | BRSK2 | 0.45481136 |
| 82 | NUAK1 | 0.45160403 |
| 83 | MAP3K2 | 0.44369160 |
| 84 | STK10 | 0.43731734 |
| 85 | PIM2 | 0.42901488 |
| 86 | PLK3 | 0.42867355 |
| 87 | PDK1 | 0.40543644 |
| 88 | AURKA | 0.38465605 |
| 89 | CSNK2A1 | 0.37560116 |
| 90 | TRIM28 | 0.37403446 |
| 91 | BRD4 | 0.37248866 |
| 92 | CSNK2A2 | 0.36878586 |
| 93 | CDC42BPA | 0.36118010 |
| 94 | PRKCG | 0.34481429 |
| 95 | SGK3 | 0.34193114 |
| 96 | MELK | 0.33316632 |
| 97 | PASK | 0.32502471 |
| 98 | MAP3K1 | 0.29615275 |
| 99 | CSNK1E | 0.29598288 |
| 100 | FER | 0.29337673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.58831220 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.08826527 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.04787874 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.53545847 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.50072679 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28170018 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.27060668 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.09808111 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.94779714 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 1.94580236 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 1.86698008 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.83219894 |
| 13 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.83135644 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.83022994 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80502740 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.80285964 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78439943 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.73457757 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.71881655 |
| 20 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.69215873 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.63339656 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.53087872 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46504920 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.45929704 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41879373 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.40202258 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39715321 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.37535610 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35740978 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34770525 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34587086 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.33164419 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.31305930 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29458962 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.28026439 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22962157 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22674175 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19520630 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19218412 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18676121 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16859021 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14862996 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13714914 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13464277 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12850959 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10003055 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.06965099 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06153631 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.05682760 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04791671 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01852058 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00385310 |
| 53 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97874176 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97621321 |
| 55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95091868 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.93979486 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93404522 |
| 58 | RNA polymerase_Homo sapiens_hsa03020 | 0.93163431 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92774013 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92669993 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90465356 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88245635 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87493375 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.87333399 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86315158 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.84843473 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84503372 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79732525 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78002195 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.76145116 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76041195 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74850537 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.71615633 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.68965155 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67003182 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66958176 |
| 77 | Protein export_Homo sapiens_hsa03060 | 0.65310679 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.65005469 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63555352 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.59741363 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57043280 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56832554 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55760796 |
| 84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53373927 |
| 85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52767945 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.49244732 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48479095 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47341912 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45941289 |
| 90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44595200 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41793505 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41492306 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.40474381 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.38634093 |
| 95 | DNA replication_Homo sapiens_hsa03030 | 0.38178589 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37572282 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35511418 |
| 98 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35475254 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34678646 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.34608183 |

